|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
InVivo Therapeutics Holdings Corp.
| | | Phone: | (617) 863-5500 | Year Established: | 2005 | Ticker: | NVIV | Exchange: | NASDAQ | Main Contact: | Pamela Stahl, CCO | | Other Contacts: | Melanie Morel-Ferris, C.P.A., Senior Director, Finance and Controller Lisa Crockett, VP, Regulatory Affairs & Reimbursement Planning Kristin Neff, VP, Clinical Operations & Project Management William D'Agostino, Senior VP, Operations Tamara L. Joseph, J.D., Senior VP, General Counsel/Chief Compliance Officer Thomas R. Ulich, M.D., CSO Lou Vaickus, M.D., Interim CMO Mark D. Perrin, CEO & Chairman
| | Company Description | is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc.D., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who then was at Boston Children’s Hospital and who now is affiliated with Massachusetts General Hospital. In 2011, the company earned the David S. Apple Award from the American Spinal Injury Association for its outstanding contribution to spinal cord injury medicine. In 2015, the company’s investigational Neuro-Spinal Scaffold received the 2015 Becker’s Healthcare Spine Device Award. | |
|
|
|
|
|